The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways
(2023). The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways. EKB Journal Management System, 3(2), -. doi: 10.21608/esdlj.2023.456215
. "The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways". EKB Journal Management System, 3, 2, 2023, -. doi: 10.21608/esdlj.2023.456215
(2023). 'The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways', EKB Journal Management System, 3(2), pp. -. doi: 10.21608/esdlj.2023.456215
The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways. EKB Journal Management System, 2023; 3(2): -. doi: 10.21608/esdlj.2023.456215